BETA

1 Plenary speeches of Miroslav POCHE related to 2016/2978(RSP)

Objection pursuant to Rule 106 : Renewing the approval of the active substance bentazone (B8-1228/2016) CS
2016/11/22
Dossiers: 2016/2978(RSP)